Loading...

XAIR BEYOND AIR INC Management Changes 8-K Filing

BYND

XR

BEYOND AIR INC

(XAIR)

2025 8-K

Show Summary

Summary

Reverse Stock Split

Share Sale Agreement

Management Change

Equity Offering

Financial Results

Nasdaq Compliance Notice

Accounting Firm Change

Clinical Trial Approval

CE Mark Approval

Annual Meeting Results

Financial Results

Annual Meeting Notice

Securities Offering

Financial Results and Delis...

Loan Agreement Amendment an...

Equity Incentive Plan Approval

Termination of Sales Agreement

Financial Results and Consu...

Earnings Reports

Earnings Report

Financial Results Announcement

Equity Incentive Plan Approved

Earnings Report

External Links:

On June 17, 2025, Beyond Air, Inc. announced its financial results for the fiscal quarter and year ended March 31, 2025, and appointed Robert Goodman as a new director on June 16, 2025. The company also submitted a PMA supplement application to the FDA on June 16, 2025, for its LungFit PH II device.

AI Assistant

BEYOND AIR INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.